Infinex: We messed up the public offering and will revise the specific rules
Odaily reported that Infinex officially announced on X: "We messed up this public sale. We tried to balance both existing Patron holders and new participants, aiming for a fair distribution, but the result was a sale that (almost) no one wanted to join. Retail investors hate lock-ups, whales hate caps. Everyone hates complexity. The community has been reminding us, and you were right. We apologize for the way we handled this. Therefore, we will adjust this public sale in the following ways."
The specific adjustments include:
1. Removing the cap: There will no longer be a maximum limit of $2,500. Users can contribute any amount they wish; you can invest as much as you want. We will no longer try to guess a "correct number" and will let the market decide.
2. Adopting a bottom-up allocation mechanism: We will cancel the random allocation and switch to a water filling mechanism, meaning each person's allocation will increase simultaneously and evenly until their individual cap is reached or the total supply is exhausted. Any excess contributions will be refunded.
3. Patron priority remains: Patrons will still enjoy allocation priority, but we will finalize the specific rules after the sale ends—once we have real demand data, instead of continuing to guess.
4. The lock-up mechanism will not be canceled: We still believe that lock-ups can bring long-term alignment of interests for those who truly believe in the product.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Pfizer (PFE.US), BioNTech (BNTX.US), and Moderna (MRNA.US) seek dismissal of Bayer’s Monsanto mRNA patent lawsuit, but the judge rejects the request
A federal judge in Delaware on Monday rejected the requests from Pfizer, BioNTech, and Moderna to dismiss a lawsuit filed against them by Monsanto, a subsidiary of the German pharmaceutical giant Bayer. The lawsuit concerns these pharmaceutical companies' use of a patent related to mRNA technology.
After years of waiting and another delay, Tesla (TSLA.US) postpones the Roadster debut to October 15 as severe weather forces the event to stop.
Tesla has rescheduled the unveiling event for its next-generation Roadster, originally planned for this week, to October 15.
Debt and inflation become the biggest constraints! Deutsche Bank warns: The global market "policy safety net" is failing and future volatility may intensify
Deutsche Bank Research stated in its latest report that the era of large-scale policy interventions used to cushion global economic shocks over the past decades is coming to an end. The continuous rise in sovereign debt, high interest rates, and persistent inflation are all weakening the traditional “safety net” relied upon by governments and central banks.
Bellock executive Lee Young Hoon lifts stake to 0.99% from 0.56%
